Compare Ascendis Pharma A/S (ASND) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs HCA Health Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while HCA Health Inc trades at $411.49 (market cap $89.08B). The key difference: HCA Health Inc is far larger — about 5.3× Ascendis Pharma A/S's market cap, and HCA Health Inc pays a 0.76% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | HCA | |
|---|---|---|
Market Cap | $16.67B | $89.08B |
Sector | Health | Health |
52-Week High | $277.18 | $545.13 |
52-Week Low | $189.74 | $361.32 |
Enterprise Value | $17.04B | $139.62B |
Dividend Yield | — | 0.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
